Key Dates

  • Board Meeting Date: Wednesday, August 12, 2026
  • Quarter Ended: June 30, 2026 (Q1 FY27)
  • Trading Window Closure Period: July 1, 2026 to August 14, 2026 (both days inclusive)

Meeting Agenda

The Board of Directors will meet in Mumbai to consider and approve:

  • Unaudited Financial Results (Standalone)
  • Unaudited Financial Results (Consolidated)

Document Availability

The intimation is available on:

  • Company website: www.marksanspharma.com
  • BSE website: www.bseindia.com
  • NSE website: www.nseindia.com